Disposal

6 May 2014

Rexam completes sale of the Pharmaceutical Devices and Prescription Retail Packaging divisions of its Healthcare business

Rexam PLC confirms that it has completed the sale of the Pharmaceutical Devices and Prescription Retail Packaging divisions of its Healthcare business to Montagu Private Equity for a total cash consideration of US$805m subject to customary closing adjustments.

As previously announced, following completion Rexam proposes to return £450m of the proceeds to shareholders by way of a B and C share scheme together with a share capital consolidation. Rexam anticipates that a circular regarding the proposed return of cash, and including notice of a general meeting, will be sent to shareholders on or about 13 May 2014.

Enquiries

Investors

Sandra Moura, Head of Investor Relations, Rexam +44 20 7227 4100

Media

Jonathan Thornton, Head of Communications, Rexam +44 20 7227 4100

Katharine Wynne, Tulchan Communications +44 20 7353 4200

Martin Robinson, Tulchan Communications +44 20 7353 4200

Editors' notes:

Rexam is a leading global beverage can maker. We are business partners to some of the world's most famous and successful consumer brands. Our vision is to be the best beverage can maker in the world.We have 55 manufacturing plants in more than 20 countries and employ around 8,000 people. Our sales from continuing operations in 2013 were £3.9 billion.Rexam is a member of the FTSE 100 and its ordinary shares are listed with the UK Listing Authority and trade on the London Stock Exchange under the symbol REX. Visit www.rexam.com for further information.